Pleuropulmonary blastoma: a single-institution experience

Area of Science:

• Pediatric Oncology
• Thoracic Surgery
• Medical Malignancies

Background:

• Pleuropulmonary blastoma (PPB) is a rare intrathoracic mesenchymal malignancy exclusively affecting young children.
• This study reviews cases diagnosed between 1979 and 2009, categorizing them by type (I, II, III).

Purpose of the Study:

• To evaluate the efficacy of upfront complete tumor resection versus neoadjuvant chemotherapy and surgery for pediatric PPB.
• To determine prognostic factors influencing survival in patients with PPB.

Main Methods:

• Retrospective analysis of 12 pediatric patients diagnosed with PPB.
• Treatment modalities included upfront surgery, neoadjuvant chemotherapy followed by surgery, and radiation therapy.
• Chemotherapy regimens varied, with most patients receiving standard agents and some receiving additional agents.

Main Results:

• Upfront complete tumor resection was successful in 5 of 6 patients.
• The 5-year event-free survival was 33% ± 14%, and overall survival was 42% ± 14%.
• Gross total resection correlated with survival, while gross residual disease led to mortality. Radiation was not required for all survivors.

Conclusions:

• A high index of suspicion for PPB is crucial in pediatric patients with intrathoracic sarcoma.
• Gross total resection is the most critical factor for achieving a cure in PPB.
• Selected pediatric PPB patients may not require radiation therapy post-surgery.